StratCare Trial 2: Evaluating the Clinical and Cost-effectiveness of AI-driven Stratified Care for Depression

NANot yet recruitingINTERVENTIONAL
Enrollment

1,252

Participants

Timeline

Start Date

July 7, 2025

Primary Completion Date

May 31, 2026

Study Completion Date

November 30, 2026

Conditions
Depression
Interventions
DEVICE

StratCare

The StratCare app is a technology that collects data, processes inputs using a machine learning algorithm, and outputs a personalised treatment recommendation using automated decision rules. The inputs for the algorithm include patient-reported measures of depression, anxiety, functional impairment, personality traits, employment status and ethnic background. The algorithm calculates an expected prognosis (i.e., a probability of full remission of depression and anxiety symptoms after treatment), based on which patients are classified as standard (better expected prognosis) or complex cases. Standard cases are matched to low-intensity treatments and later have the option to move to high-intensity, whereas complex cases are matched directly to high-intensity treatments. In addition, the StratCare app is programmed to implement decision rules that ensure compliance with national clinical guidelines for the treatment allocation of patients with specific disorders.

Trial Locations (1)

DN4 8QN

Rotherham Doncaster and South Humber NHS Foundation Trust, Doncaster

All Listed Sponsors
collaborator

University of Sheffield

OTHER

collaborator

FSA Research Consulting Inc

UNKNOWN

lead

Rotherham Doncaster and South Humber NHS Foundation Trust

OTHER_GOV

NCT06567340 - StratCare Trial 2: Evaluating the Clinical and Cost-effectiveness of AI-driven Stratified Care for Depression | Biotech Hunter | Biotech Hunter